| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.032 | 0.8 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.044 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |